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both 25(OH)D (r = 0.683; p = 0.001) and PTHi (r = 0.467; p = 0.001) 
blood levels between summer and winter.
Groups of Vitamin D  
ng/ml
Normal  
(> 30)
Insufficiency 
(21-29)
Deficiency  
(< 20)
Summer 37.0 (± 1.0) 24.7 (± 0.27) 16.9 (± 4.1)
Winter 33.2 (± 0.8) 23.4 (± 0.4) 14.3 (± 0.3)
Summer n (%) 48 (24.6) 100 (51.3) 47 (24.1)
Winter n (%) 3 (1.9) 23 (14.4) 134 (83.8)
Conclusions: Significant variations summer/winter of both 
25(OH)D and iPTH blood levels, were found in this healthy young 
adult population. Also, the means of 25(OH)D were relatively low, 
suggesting that many young adults have already levels of deficiency/
insufficiency, such as was described in other south European coun-
tries; however, the clinical significance of such inadequate levels still 
remains unclarified.
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Introduction: BMD and blood vitamin D concentrations decline 
slowly with ageing, as falls and osteoporotic fractures increase 
among elderly people. The bone quality may be accessed by trabec-
ular bone score (TBS); together, TBS and DXA may evidence bone 
strength. However, data about the influence of vitamin D on the TBS 
are scarce.
Objectives: To evaluate the influence of the blood vitamin D lev-
els on the BMD and TBS in normal men.
Methods: The bone mineral content (BMC, g), BMD (g/cm2), and 
TBS (obtained from DXA scan) at the lumbar spine were evaluated in 
a group of normal men aged ≥ 40 years. Fasting blood collections 
were performed for measurements of the osteocalcin, 25(OH)D and 
iPTH concentrations. These men were divided in the normal, low 
BMD and osteoporosis groups, as well as in the normal, insufficiency 
and deficiency vitamin D groups (ES Guidelines). Total body fat and 
lean masses were also calculated. Adequate statistical tests were 
used (statistical significance p < 0.05).
Results: Men of deficiency group were heavier and with the lower 
TBS. The mean (± SD) osteocalcin, iPTH, 25(OH)D and TBS of the BMD 
are shown in the table. Significant correlation coefficients were de-
tected between the blood 25(OH)D vs weight, vs total fat mass and 
vs TBS but not vs BMD.
Groups variable Normal (50.0%) Low BMD (41.1%) Osteoporosis (8.9%) p
Osteocalcin ng/ml 17.6 (± 1.6) 18.8 (± 1.7) 25.7 (± 3.7) NSD
iPTH pg/ml 46.5 (± 6.5) 61.4 (± 7.0) 60.5 (± 15.0) NSD
25(OH)D ng/ml 20.6 (± 1.8) 20.2 (± 2.0) 18.8 (± 4.4) NSD
TBS L1-L4 1.334 (± 0.1) 1.319 (± 0.1) 1.281 (± 0.1) NSD
Conclusions: Blood 25(OH)D levels may play an important role on 
the bone quality accessed by TBS in vitamin D deficient men, as they 
have worse bone quality. The data suggest that more studies are 
needed on larger cohort of men and it might be worth to investigate 
also elderly men with osteomalacia.
WCO04. ASSOCIATION BETWEEN SUBCLINICAL AND 
OVERT HYPERTHYROIDISM, VITAMIN D AND BONE 
DENSITY CHANGES
Volodymyr Pankiv1, Ivan Pankiv2
1Ukrainian Scientific Centre of Endocrine Surgery, Kyiv. 2Higher State 
Educational Institution of Ukraine “Bukovinian State Medical 
University”, Chernivtsi, Ukraine.
Introduction: Patients with thyroid autoimmune diseases have 
lower blood level of vitamin D by comparison to a general popula-
tion. However, there are few studies examining vitamin D status in 
patients with subclinical and overt hyperthyroidism depending on 
the degree of disease compensation.
Objectives: The aim of this study was determination of blood 
25(OH)D level in patients with subclinical and overt hyperthyroid-
ism, and also his possible influence on disease progression.
Methods: 80 patients of reproductive age with thyrotoxicosis 
syndrome were recruited. The thyroid functional state was esti-
mated by means of determination of thyroid-stimulating hormone 
(TSH) basal concentrations and free thyroxine in the blood serum. 
Subjects were invited to attend quantitative ultrasound densitome-
try (Sahara), and a fasting blood sample from which osteocalcin, se-
rum N-terminal propeptide of type 1 procollagen and crosslinks 
were also measured.
Results: 25(OH)D level (14.9 ± 1.8 ng/ml) was significantly lower 
in patients with diffuse toxic goiter in the state of sub- and decom-
pensation, comparatively with the group of women with diffuse 
toxic goiter in the state of stabile thyrotoxicosis compensation (21.2 
± 2.4 ng/ml) and control group (23.9 ± 2.7 ng/ml). The results of cor-
relation analysis testify to the presence in patients with diffuse toxic 
goiter in the state of thyrotoxicosis sub- and decompensation signifi-
cant negative connection between blood 25(OH)D and level of thy-
rotropin receptor antibodies (r = -0.47; p < 0.05). Frequency of bone 
mineral density disorders in patients with thyrotoxicosis syndrome 
was 52.7%, including osteopenia in 40% and osteoporosis in 12.7%. 
A basic factor that results in the decline of bone mineral density in 
patients with thyrotoxicosis syndrome is excessive products of thy-
roid hormones, and also TSH-suppressive doses of levothyroxine.
Conclusions: The vitamin D blood level depends on the degree 
of thyrotoxicosis compensation. Significant association between 
25(OH)D range and level of thyrotropin receptor antibodies estab-
lished in the group of patients with an uncompensated thyrotoxi-
cosis.
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Introduction: Some recent epidemiological studies suggest an 
important role for vitamin D in the glycemic and lipid homeostasis.
Objectives: Longitudinal study to evaluate the possible effects of 
vitamin D supplementation in several cardio-metabolic and anthro-
pometric variables of people affected by type 2 diabetes mellitus.
Methods: 21 T2DM women treated with oral antidiabetics of the 
bone metabolic diseases out-patient clinic were evaluated before and 
one year after beginning the supplementation with vitamin D. 
Fasting blood was collected for 25-hydroxy-vitamin D [25(OH)D], 
glucose, HbA1c, total cholesterol, LDL- and HDL- cholesterol and trig-
lycerides measurements. Total body fat mass and fat percentage 
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were accessed by DXA. Body mass index (BMI) was also calculated. 
Adequate statistical tests were used (statistical significance p < 0.05).
Results: The mean 25(OH)D after supplementation with vita-
min D was significantly higher :16.2 (± 6.7) vs 26.6 (± 9.1) ng/ml, p 
< 0.05. A significant reduction in the mean total cholesterol [180.3 
(± 20.2) vs 164.6 (± 21.9) mg/dl, p = 0.033) was detected after one 
year of vitamin D supplementation. However, no changes were 
observed in the mean LDL-cholesterol, HDL-cholesterol, triglyc-
erides, glycaemia, HbA1c neither in the means of other anthropo-
metric variables.
Conclusions: In T2DM women treated with antidiabetic oral 
medications and supplementation with vitamin D, a significant in-
crease in the mean total cholesterol was observed and no change in 
the glycemic control or the remaining lipid profile was detected. The 
results of this study are consistent with the data of recent studies, 
which suggest that vitamin D is a possible marker of the general 
health, but not a potential therapy for T2DM.
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Introduction: We have seen no well-defined approach to calcu-
lating vitamin D dose in patients with musculoskeletal system dis-
eases and vitamin D deficiency.
Objectives: To assess the efficacy and safety of individual tar-
geted vitamin D therapy in postmenopausal women with skeletal 
diseases (systemic osteoporosis and osteoarthritis).
Methods: Individual targeted therapy of vitamin D deficiency 
consists of two periods – saturation period and maintenance therapy 
period, during which patients take it constantly. Duration of satura-
tion therapy is calculated by the formula: Saturation therapy dura-
tion (days) = (100 – blood 25(OH)D level (ng/mL)) × body weight 
(kg)/100, The therapy for saturation includes combined calcium 
(1,000 mg of calcium and 800 IU of vitamin D) and 3,000 IU of vita-
min D per day. Maintenance therapy includes 2 000 IU of vitamin D 
per day. The study involved 70 postmenopausal women aged 46-87 
years. All patients were divided into two groups: main. 50 women 
who took individual targeted vitamin D therapy (50 subjects, 65.1 ± 
8.8 years old, BMI 27.22 ± 4.51 kg/m2) and control (20 subjects, 64.5 
± 11.1 years old, BMI 26.68 ± 4.95 kg/m2). The duration of the treat-
ment consists of 3 months starting on the 1st Oct 2013.
Results: In 3 months after the start of the treatment there was a 
significant (p < 0.001) increase in 25(OH)D levels in the treatment 
group: 35.60 ± 8.21 nmol/L as compared to baseline levels of 25.20 ± 
9.76 nmol/l. Remarkably, the treatment was most effective in the oldest 
subgroup (> 70 yrs.), as well as in subjects with the BMI 25-28,99 kg/m2. 
After the treatment, there were no changes in calcium levels.
Conclusions: The suggested individual targeted vitamin D ther-
apy was proven to be effective in postmenopausal women. As the 
treatment turned out to be effective, relatively quick, and had a rea-
sonable safety profile it may be beneficial for all vitamin D deficient 
postmenopausal women.
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Objective: The aim of our study was to evaluate the prevalence of 
hypovitaminosis D and the associations between 25(OH)D and PTH 
serum levels in a sample of individuals representative of the main-
land Portuguese population.
Material and methods: PORMETS is a national cross-sectional 
study of a representative sample of 4095 non-institutionalized 
adults, selected from the primary health care centers lists. 500 par-
ticipants (286 women and 214 men) were randomly selected to be 
included in the present study. A fasting venous blood sample was 
collected and freezing samples were stored at –80º C. Vitamin D ad-
equacy was classified according to IOM criteria. A “blunted PTH re-
sponse” was defined as a PTH within the reference range in the 
presence of a 25OHD < 12 ng/mL.
Results: Mean (standard deviation) 25(OH)D levels were 14.1 
(5.8) ng/mL. According to Vitamin D adequacy categories, deficiency 
was present in 37.7 %, insufficiency in 47.9%, inadequate in 13.8% and 
optimal levels in 0.6% of the participants. PTH and 25(OH)D levels 
were not significantly correlated and a “blunted PTH response” was 
presented in 89.0% of the participant with vitamin D deficiency.
Conclusions: A high prevalence of hypovitaminosis D was ob-
served in this Portuguese population-based study. These results are 
supported by previously published evidence from Portugal, although 
in specific population groups recruited in hospital setting. Attending 
to low levels and inadequate intake of Vitamin D and possible insuf-
ficient solar exposure in the general population it is urgent to devel-
op national policies to increase awareness of the importance of 
Vitamin D for good health and to develop strategies for the diagnosis 
and treatment of hypovitaminosis D, namely in at-risk groups. Food 
fortification may also deserve a broad national debate and lifestyle 
changes, including weight control and outdoor physical activity 
must also be encouraged.
